Nomura Holdings Inc vs Smith & Nephew plc — how do they compare? Nomura Holdings Inc trades at $9.4 (market cap $27.46B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Nomura Holdings Inc is far larger — about 2.2× Smith & Nephew plc's market cap, and Nomura Holdings Inc pays the higher dividend (3.45%). Which is the better fit depends on your goals.
| NMR | SNN | |
|---|---|---|
Market Cap | $27.46B | $12.64B |
Sector | Financials | Health |
52-Week High | $10.04 | $38.70 |
52-Week Low | $6.39 | $28.73 |
Dividend Yield | 3.45% | 2.57% |
Enterprise Value | — | $15.41B |
Trailing returns across standard periods
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →